In line with this, OAd.TNFa-IL2 was created and it has shown great promise in vivo by curing 80% of Syrian Hamsters as a single treatment and 100% of the animals when given as a combination treatment with Tumor- infiltrating lymphocyte (TIL) therapy [6]. This evidence concerns the gene IL2 and neoplasm.